90 related articles for article (PubMed ID: 43210)
1. Comparative effects of benzodiazepines and non-benzodiazepine anxiolytics on biochemical and behavioral tests predictive of anxiolytic activity.
Malick JB; Enna SJ
Commun Psychopharmacol; 1979; 3(4):245-52. PubMed ID: 43210
[No Abstract] [Full Text] [Related]
2. CR 2945: a novel CCKB receptor antagonist with anxiolytic-like activity.
Revel L; Mennuni L; Garofalo P; Makovec F
Behav Pharmacol; 1998 May; 9(3):183-94. PubMed ID: 9832933
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of anxiolytics and beta-receptor blocking drugs on novelty-oriented ("neophobic") behavior in the rat.
Delini-Stula A; Hunn C
Pharmacopsychiatry; 1988 Jul; 21(4):186-91. PubMed ID: 2905063
[TBL] [Abstract][Full Text] [Related]
4. 5-ethoxymethyl-7-fluoro-3-oxo-1,2,3,5-tetrahydrobenzo[4,5]imidazo[1,2a]pyridine-4-N-(2-fluorophenyl)carboxamide (RWJ-51204), a new nonbenzodiazepine anxiolytic.
Dubinsky B; Vaidya AH; Rosenthal DI; Hochman C; Crooke JJ; DeLuca S; DeVine A; Cheo-Isaacs CT; Carter AR; Jordan AD; Reitz AB; Shank RP
J Pharmacol Exp Ther; 2002 Nov; 303(2):777-90. PubMed ID: 12388665
[TBL] [Abstract][Full Text] [Related]
5. Effects of anxiolytic drugs on some behavioral consequences in olfactory bulbectomized rats.
Wierońska JM; Papp M; Pilc A
Pol J Pharmacol; 2001; 53(5):517-25. PubMed ID: 11990071
[TBL] [Abstract][Full Text] [Related]
6. Selective anxiolytics: are the actions related to partial "agonist" activity or a preferential affinity for benzodiazepine receptor subtypes?
Gee KW; Yamamura HI
Adv Biochem Psychopharmacol; 1983; 38():1-9. PubMed ID: 6142598
[TBL] [Abstract][Full Text] [Related]
7. The pharmacological profile of chlordesmethyldiazepam and other benzodiazepines.
Chojnacka-Wójcik E; Tatarczyńska E; Wiczyńska B; Lewandowska A; Przegaliński E
Pol J Pharmacol Pharm; 1986; 38(2):207-13. PubMed ID: 2875452
[TBL] [Abstract][Full Text] [Related]
8. [The behavioral characteristics of young and sexually mature animals administered fenazepam, gidazepam and medazepam].
Voronina TA; Molodavkin GM; Ramkhin EIa
Eksp Klin Farmakol; 1993; 56(3):3-5. PubMed ID: 8106053
[TBL] [Abstract][Full Text] [Related]
9. Some behavioral effects of chlorodesmethyldiazepam and lorazepam.
Kostowski W; Płaźnik A; Puciłowski O; Trzaskowska E; Lipińska T
Pol J Pharmacol Pharm; 1981; 33(6):597-602. PubMed ID: 6127668
[TBL] [Abstract][Full Text] [Related]
10. Subacute benzodiazepine treatment: observations on behavioural tolerance and withdrawal.
Gonzalez JP; McCulloch AJ; Nicholls PJ; Sewell RD; Tekle A
Alcohol Alcohol; 1984; 19(4):325-32. PubMed ID: 6152398
[TBL] [Abstract][Full Text] [Related]
11. Discriminative stimulus effects of positive GABAA modulators and other anxiolytics, sedatives, and anticonvulsants in untreated and diazepam-treated monkeys.
McMahon LR; France CP
J Pharmacol Exp Ther; 2003 Jan; 304(1):109-20. PubMed ID: 12490581
[TBL] [Abstract][Full Text] [Related]
12. The anxiolytic-like effect of 5-HT1B receptor ligands in rats: a possible mechanism of action.
Chojnacka-Wójcik E; Kłodzińska A; Tatarczyńska E
J Pharm Pharmacol; 2005 Feb; 57(2):253-7. PubMed ID: 15720791
[TBL] [Abstract][Full Text] [Related]
13. Behavioral effects of psychotherapeutic agents in rats chronically dosed with alpha-acetylmethadol.
Maickel RP; Lambert CS; Braude MC; Zabik JE
Commun Psychopharmacol; 1978; 2(1):45-50. PubMed ID: 26496
[No Abstract] [Full Text] [Related]
14. Evaluation of chalcones--a flavonoid subclass, for, their anxiolytic effects in rats using elevated plus maze and open field behaviour tests.
Jamal H; Ansari WH; Rizvi SJ
Fundam Clin Pharmacol; 2008 Dec; 22(6):673-81. PubMed ID: 19049672
[TBL] [Abstract][Full Text] [Related]
15. Potential anxiolytic-like activity of some amino acid derivatives.
Paruszewski R; Kłodzińska A; Chojnacka-Wójcik E
Pharmazie; 1998 Feb; 53(2):124-5. PubMed ID: 9540109
[TBL] [Abstract][Full Text] [Related]
16. Anxiolytic activity of a novel potent serotonin 5-HT2C receptor antagonist FR260010: a comparison with diazepam and buspirone.
Harada K; Aota M; Inoue T; Matsuda R; Mihara T; Yamaji T; Ishibashi K; Matsuoka N
Eur J Pharmacol; 2006 Dec; 553(1-3):171-84. PubMed ID: 17074317
[TBL] [Abstract][Full Text] [Related]
17. RP 59037 and RP 60503: anxiolytic cyclopyrrolone derivatives with low sedative potential. interaction with the gamma-aminobutyric acidA/benzodiazepine receptor complex and behavioral effects in the rodent.
Doble A; Canton T; Dreisler S; Piot O; Boireau A; Stutzmann JM; Bardone MC; Rataud J; Roux M; Roussel G
J Pharmacol Exp Ther; 1993 Sep; 266(3):1213-26. PubMed ID: 8103792
[TBL] [Abstract][Full Text] [Related]
18. Pharmacology of anti-anxiety drugs with special reference to clobazam.
Fielding S; Hoffmann I
Br J Clin Pharmacol; 1979; 7 Suppl 1(Suppl 1):7S-15S. PubMed ID: 35209
[TBL] [Abstract][Full Text] [Related]
19. Behavioral analysis of the effects and mechanisms of action of benzodiazepines.
Cook L; Sepinwall J
Adv Biochem Psychopharmacol; 1975; (14):1-28. PubMed ID: 242196
[TBL] [Abstract][Full Text] [Related]
20. [Changes in the GABA-transaminase activity in various structures of the rat brain after administration of benzodiazepine tranquilizers].
Galust'ian GE; Ignatov IuD
Biull Eksp Biol Med; 1983 Jan; 95(1):56-8. PubMed ID: 6131706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
